Physician profile
Jeffrey M Goodloe
NPI 1285610428
$15,830.04
in general payments reported to CMS, 2019-2025
17 companies · $5,103 in 2025
The $5,103 reported for 2025 was more than what 98% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,727 · 2020: $48.43 · 2021: $515 · 2022: $848 · 2023: $666 · 2024: $6,923 · 2025: $5,103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,258 · Food and Beverage: $3,493 · Travel and Lodging: $2,712 · Consulting Fee: $630 · Honoraria: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,257.50 |
| Food and Beverage | $3,492.64 |
| Travel and Lodging | $2,712.20 |
| Consulting Fee | $630.00 |
| Honoraria | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,849.90 | 2024-2025 | Microstream, Invos |
| Stryker Corporation | $2,438.34 | 2019-2025 | Lifepak 35, Lifepak 15 Monitor/Defibrillator, Physio - Lucas |
| Btg International INC. | $1,417.73 | 2019 | |
| Pfizer INC. | $1,055.99 | 2024-2025 | |
| Abiomed | $929.53 | 2025 | |
| Purdue Pharma L.P. | $600.00 | 2025 | Nalmefene Hydrochloride |
| Astrazeneca Pharmaceuticals LP | $539.12 | 2021-2024 | Andexxa |
| Vertex Pharmaceuticals Incorporated | $224.17 | 2025 | |
| Brainscope Company, INC. | $155.97 | 2021 | |
| Covidien LP | $148.82 | 2019 | |
| Inari Medical, INC. | $143.67 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Vapotherm INC | $119.33 | 2021-2023 | Vapotherm |
| Janssen Pharmaceuticals, INC | $69.29 | 2019-2023 | Xarelto |
| Zoll Medical Corporation | $48.43 | 2020 | |
| Grifols USA, LLC | $45.20 | 2025 | Hyperrab |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher & Paykel Healthcare INC | $31.07 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Goodloe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.